Regulus Therapeutics Inc.
RGLSCIK 0001505512 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2025. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone 0.0033
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Regulus Therapeutics Inc.
| Name | Roles | Filings |
|---|---|---|
| Rosen Hugh | Director | 7 |
| Witz Pascale | Director | 7 |
| Drygin Denis | Officer | 3 |
| Simeonidis Simos | Director | 1 |
Showing 11-14 of 14
PrevPage 3 of 3
All filings
108 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|